Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
A.M. Buccoliero, F. Castiglione, D. Rossi Degl'innocenti, M. Paglierani, V. Maio, C.F. Gheri, F. Garbini, D. Moncini, A. Taddei, I. Sardi, M. Sanzo, F. Giordano, F. Mussa, L. Genitori & G.L. Taddei. (2008) O6- Methylguanine-DNA-Methyltransferase in Recurring Anaplastic Ependymomas: PCR and Immunohistochemistry. Journal of Chemotherapy 20:2, pages 263-268.
Read now
Read now
Articles from other publishers (7)
Nanna Lindberg & Lene Uhrbom. 2013. Animal Models of Brain Tumors. Animal Models of Brain Tumors
57
82
.
Prerana Jha, Vaishali Suri, Ayushi Jain, Mehar Chand Sharma, Pankaj Pathak, Pankaj Jha, Arti Srivastava, Ashish Suri, Deepak Gupta, Kunzang Chosdol, Parthoprasad Chattopadhyay & Chitra Sarkar. (2010) O 6-Methylguanine DNA Methyltransferase Gene Promoter Methylation Status in Gliomas and Its Correlation With Other Molecular Alterations: First Indian Report With Review of Challenges for Use in Customized Treatment. Neurosurgery 67:6, pages 1681-1691.
Crossref
Crossref
Matthias Preusser, Robert Charles Janzer, Jörg Felsberg, Guido Reifenberger, Marie‐France Hamou, Annie‐Claire Diserens, Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl, Johannes A Hainfellner & Monika Hegi. (2008) Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker*. Brain Pathology 18:4, pages 520-532.
Crossref
Crossref
Fausto J. Rodriguez, Stephen N. Thibodeau, Robert B. Jenkins, Karen V. Schowalter, Bolette L. Caron, Brian P. O'Neill, Charles David James, Sandra Passe, Jeff Slezak & Caterina Giannini. (2008) MGMT Immunohistochemical Expression and Promoter Methylation in Human Glioblastoma. Applied Immunohistochemistry & Molecular Morphology 16:1, pages 59-65.
Crossref
Crossref
David SchiffPaul D. BrownCaterina Giannini. (2007) Outcome in adult low-grade glioma. Neurology 69:13, pages 1366-1373.
Crossref
Crossref
Iris Lavon, Daniel Zrihan, Bracha Zelikovitch, Yakov Fellig, Dana Fuchs, Dov Soffer & Tali Siegal. (2007) Longitudinal Assessment of Genetic and Epigenetic Markers in Oligodendrogliomas. Clinical Cancer Research 13:5, pages 1429-1437.
Crossref
Crossref
Kurt A. Jaeckle, Karla V. Ballman, Ravi D. Rao, Robert B. Jenkins & Jan C. Buckner. (2006) Current Strategies in Treatment of Oligodendroglioma: Evolution of Molecular Signatures of Response. Journal of Clinical Oncology 24:8, pages 1246-1252.
Crossref
Crossref